Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: IMMUNOLOGIC FACTORS - THERAPEUTIC USE , . Treffer: 25
2021
Canzian, A; Venhoff, N; Urban, ML; Sartorelli, S; Ruppert, AM; Groh, M; Girszyn, N; Taillé, C; Maurier, F; Cottin, V; de, Moreuil, C; Germain, V; Samson, M; Jachiet, M; Denis, L; Rieu, V; Smets, P; Pugnet, G; Deroux, A; Durel, CA; Aouba, A; Cathébras, P; Deligny, C; Faguer, S; Gil, H; Godeau, B; Lifermann, F; Phin-Huynh, S; Ruivard, M; Bonniaud, P; Puéchal, X; Kahn, JE; Thiel, J; Dagna, L; Guillevin, L; Vaglio, A; Emmi, G; Terrier, B, , French, Vasculitis, Study, Group, and, the, European, EGPA, Study, Group
Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study.
Arthritis Rheumatol. 2021; 73(3): 498-503.
Doi: 10.1002/art.41534
Web of Science
PubMed
FullText
FullText_MUG
Guetl, K; Gary, T; Raggam, RB; Schmid, J; Wölfler, A; Brodmann, M
SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban.
Lancet. 2021; 397(10293):e19
Doi: 10.1016/S0140-6736(21)01238-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Gauckler, P; Shin, JI; Alberici, F; Audard, V; Bruchfeld, A; Busch, M; Cheung, CK; Crnogorac, M; Delbarba, E; Eller, K; Faguer, S; Galesic, K; Griffin, S; Hrušková, Z; Jeyabalan, A; Karras, A; King, C; Kohli, HS; Maas, R; Mayer, G; Moiseev, S; Muto, M; Odler, B; Pepper, RJ; Quintana, LF; Radhakrishnan, J; Ramachandran, R; Salama, AD; Segelmark, M; Tesař, V; Wetzels, J; Willcocks, L; Windpessl, M; Zand, L; Zonozi, R; Kronbichler, A, ;RITERM, study, group;RITERM, study, group
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Autoimmun Rev. 2020; 19(11):102671
Doi: 10.1016/j.autrev.2020.102671
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Brandner, M; Hubmann, H; Langmann, A
Acute Bilateral Tonic Pupil in a Child.
JAMA Ophthalmol. 2017; 135(11):1272-1273
Doi: 10.1001/jamaophthalmol.2017.2304
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Fasching, P; Stradner, M; Graninger, W; Dejaco, C; Fessler, J
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.
Molecules. 2017; 22(1):
Doi: 10.3390/molecules22010134
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Robier, C; Amouzadeh-Ghadikolai, O; Bregant, C; Diez, J; Melinz, K; Quehenberger, F; Quasthoff, S
The frequency of occurrence of atypical lymphocytes in peripheral blood smears of natalizumab-treated patients with multiple sclerosis.
Int J Lab Hematol. 2017; 39(5):469-474
Doi: 10.1111/ijlh.12662
Web of Science
PubMed
FullText
FullText_MUG
Stieglbauer, K; Pichler, R; Topakian, R
10-year-outcomes after rituximab for myasthenia gravis: Efficacy, safety, costs of inhospital care, and impact on childbearing potential.
J Neurol Sci. 2017; 375(2): 241-244.
Doi: 10.1016/j.jns.2017.02.009
Web of Science
PubMed
FullText
FullText_MUG
2016
Schauberger, E; Peinhaupt, M; Cazares, T; Lindsley, AW
Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets.
Curr Allergy Asthma Rep. 2016; 16(7):48-48
Doi: 10.1007/s11882-016-0628-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Sormani, MP; Gasperini, C; Romeo, M; Rio, J; Calabrese, M; Cocco, E; Enzinger, C; Fazekas, F; Filippi, M; Gallo, A; Kappos, L; Marrosu, MG; Martinelli, V; Prosperini, L; Rocca, MA; Rovira, A; Sprenger, T; Stromillo, ML; Tedeschi, G; Tintorè, M; Tortorella, C; Trojano, M; Montalban, X; Pozzilli, C; Comi, G; De Stefano, N; MAGNIMS study group
Assessing response to interferon-β in a multicenter dataset of patients with MS.
Neurology. 2016; 87(2):134-140
Doi: 10.1212/WNL.0000000000002830
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Bode, SF; Ammann, S; Al-Herz, W; Bataneant, M; Dvorak, CC; Gehring, S; Gennery, A; Gilmour, KC; Gonzalez-Granado, LI; Groß-Wieltsch, U; Ifversen, M; Lingman-Framme, J; Matthes-Martin, S; Mesters, R; Meyts, I; van Montfrans, JM; Pachlopnik Schmid, J; Pai, SY; Soler-Palacin, P; Schuermann, U; Schuster, V; Seidel, MG; Speckmann, C; Stepensky, P; Sykora, KW; Tesi, B; Vraetz, T; Waruiru, C; Bryceson, YT; Moshous, D; Lehmberg, K; Jordan, MB; Ehl, S; Inborn Errors Working Party of the EBMT
The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.
Haematologica. 2015; 100(7):978-988
Doi: 10.3324/haematol.2014.121608
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Sukara, G; Baresic, M; Sentic, M; Brcic, L; Anic, B
Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus treated with rituximab: case report and a review of the literature.
Acta Reumatol Port. 2015; 40(2):169-175
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
2014
Hegen, H; Millonig, A; Bertolotto, A; Comabella, M; Giovanonni, G; Guger, M; Hoelzl, M; Khalil, M; Killestein, J; Lindberg, R; Malucchi, S; Mehling, M; Montalban, X; Polman, CH; Rudzki, D; Schautzer, F; Sellebjerg, F; Sørensen, PS; Deisenhammer, F
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.
Mult Scler. 2014; 20(5):577-587
Doi: 10.1177/1352458513503597
Web of Science
PubMed
FullText
FullText_MUG
Sitaru, C; Thiel, J
The need for markers and predictors of Rituximab treatment resistance.
Exp Dermatol. 2014; 23(4):236-7
Doi: 10.1111/exd.12331
Web of Science
PubMed
FullText
FullText_MUG
2013
Löhr, M; Molcanyi, M; Poggenborg, J; Spuentrup, E; Runge, M; Röhn, G; Härtig, W; Hescheler, J; Hampl, JA
Intracerebral administration of heat-inactivated Staphylococcus epidermidis enhances oncolysis and prolongs survival in a 9L orthotopic gliosarcoma model.
Cell Physiol Biochem. 2013; 31(4-5): 614-624.
Doi: 10.1159/000350081
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2010
Frühauf, J; Schwantzer, G; Ambros-Rudolph, CM; Weger, W; Ahlgrimm-Siess, V; Salmhofer, W; Hofmann-Wellenhof, R
Pilot study using teledermatology to manage high-need patients with psoriasis.
Arch Dermatol. 2010; 146(2): 200-201.
Doi: 10.1001/archdermatol.2009.375
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Graninger, W
Immunomodulatory therapy improves quality of life with rheumatoid arthritis].
Z Rheumatol. 2010; 69(3):210-212
Doi: 10.1007/s00393-009-0574-8
Web of Science
PubMed
FullText
FullText_MUG
Radue, EW; Stuart, WH; Calabresi, PA; Confavreux, C; Galetta, SL; Rudick, RA; Lublin, FD; Weinstock-Guttman, B; Wynn, DR; Fisher, E; Papadopoulou, A; Lynn, F; Panzara, MA; Sandrock, AW; SENTINEL Investigators
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
J Neurol Sci. 2010; 292(1-2):28-35
Doi: 10.1016/j.jns.2010.02.012
Web of Science
PubMed
FullText
FullText_MUG
2009
Heymans, S; Hirsch, E; Anker, SD; Aukrust, P; Balligand, JL; Cohen-Tervaert, JW; Drexler, H; Filippatos, G; Felix, SB; Gullestad, L; Hilfiker-Kleiner, D; Janssens, S; Latini, R; Neubauer, G; Paulus, WJ; Pieske, B; Ponikowski, P; Schroen, B; Schultheiss, HP; Tschope, C; Van Bilsen, M; Zannad, F; McMurray, J; Shah, AM
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.
Eur J Heart Fail. 2009; 11(2):119-129
Doi: 10.1093/eurjhf/hfn043
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2008
Stauder, R; Wimazal, F; Nösslinger, T; Krieger, O; Sperr, WR; Sill, H; Pfeilstöcker, M; Valent, P
Individualized management and therapy of myelodysplastic syndromes.
Wien Klin Wochenschr. 2008; 120(17-18): 523-537.
Doi: 10.1007/s00508-008-1058-6
Web of Science
PubMed
FullText
FullText_MUG
Weger, W; Aberer, E
Treatment failure with rituximab in a patient with pemphigus vulgaris.
J Eur Acad Dermatol Venereol. 2008; 22(3): 387-389.
Doi: 10.1111/j.1468-3083.2007.02340.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
2006
Feichtinger, M; Wiendl, H; Körner, E; Holl, A; Gruber, L; Fazekas, F; Schröttner, O; Eder, H; Ott, E
No effect of immunomodulatory therapy in focal epilepsy with positive glutamate receptor type 3--antibodies.
SEIZURE-EUR J EPILEP. 2006; 15(5): 350-354.
Doi: 10.1016/j.seizure.2006.03.002
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Khalil, M; Reindl, M; Lutterotti, A; Kuenz, B; Ehling, R; Gneiss, C; Lackner, P; Deisenhammer, F; Berger, T
Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.
J Neuroimmunol. 2006; 174(1-2):147-156
Doi: 10.1016/j.jneuroim.2006.01.012
Web of Science
PubMed
FullText
FullText_MUG
2004
Rieckmann, P; Toyka, KV; Bassetti, C; Beer, K; Beer, S; Buettner, U; Chofflon, M; Götschi-Fuchs, M; Hess, K; Kappos, L; Kesselring, J; Goebels, N; Ludin, HP; Mattle, H; Schluep, M; Vaney, C; Baumhackl, U; Berger, T; Deisenhammer, F; Fazekas, F; Freimüller, M; Kollegger, H; Kristoferitsch, W; Lassmann, H; Markut, H; Strasser-Fuchs, S; Vass, K; Altenkirch, H; Bamborschke, S; Baum, K; Benecke, R; Brück, W; Dommasch, D; Elias, WG; Gass, A; Gehlen, W; Haas, J; Haferkamp, G; Hanefeld, F; Hartung, HP; Heesen, C; Heidenreich, F; Heitmann, R; Hemmer, B; Hense, T; Hohlfeld, R; Janzen, RW; Japp, G; Jung, S; Jügelt, E; Koehler, J; Kölmel, W; König, N; Lowitzsch, K; Manegold, U; Melms, A; Mertin, J; Oschmann, P; Petereit, HF; Pette, M; Pöhlau, D; Pohl, D; Poser, S; Sailer, M; Schmidt, S; Schock, G; Schulz, M; Schwarz, S; Seidel, D; Sommer, N; Stangel, M; Stark, E; Steinbrecher, A; Tumani, H; Voltz, R; Weber, F; Weinrich, W; Weissert, R; Wiendl, H; Wiethölter, H; Wildemann, U; Zettl, UK; Zipp, F; Zschenderlein, R; Izquierdo, G; Kirjazovas, A; Packauskas, L; Miller, D; Koncan Vracko, B; Millers, A; Orologas, A; Panellus, M; Sindic, CJ; Bratic, M; Svraka, A; Vella, NR; Stelmasiak, Z; Selmaj, K; Bartosik-Psujik, H; Mitosek-Szewczyk, K; Belniak, E; Mochecka, A; Bayas, A; Chan, A; Flachenecker, P; Gold, R; Kallmann, B; Leussink, V; Mäurer, M; Ruprecht, K; Stoll, G; Weilbach, FX; Multiple Sclerosis Therapy Consensus Group
Escalating immunotherapy of multiple sclerosis--new aspects and practical application.
J Neurol. 2004; 251(11):1329-1339
Doi: 10.1007/s00415-004-0537-6
Web of Science
PubMed
FullText
FullText_MUG
1998
Hermann, J; Walmsley, M; Brennan, FM
Cytokine therapy in rheumatoid arthritis.
Springer Semin Immunopathol. 1998; 20(1-2):275-288
Doi: 10.1007/BF00832012
Web of Science
PubMed
FullText
FullText_MUG
1995
Gaiger, A; Henn, T; Hörth, E; Geissler, K; Mitterbauer, G; Maier-Dobersberger, T; Greinix, H; Mannhalter, C; Haas, OA; Lechner, K; Lion, T
Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression.
Blood. 1995; 86(6):2371-2378
Doi: 10.1182/blood.V86.6.2371.bloodjournal8662371
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG